Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
The Feinstein Institute for Medical Research announced today the submission of a New Drug Application to the US Food and Drug Administration (FDA) for the Fluorodopa F 18 positron emission tomography (PET) scan used to diagnose ...
Nov 14, 2012
0
0